Japan-based Toray Industries, Inc., has announced that Korean marketing partner SK Chemicals Co. has begun selling REMIT...
Gachon University, the Korea mRNA Vaccine Initiative (KmVAC), and the International Vaccine Institute (IVI) recently exc...
Celltrion Healthcare, a South Korean biopharmaceutical company specialising in the development and production of biosimi...
Southern Star Research, an Australian contract research organisation (CRO) specialising in clinical trial acceleration w...
The International Vaccine Institute (IVI), a South Korea-based international organisation devoted to vaccines for global...
South Korea-based startup Lunit has signed a software license agreement with the Hospital Israelita Albert Einstein in S...
South Korean firm Alteogen Inc has entered into an exclusive license agreement with Sandoz AG. Under the terms of t...
South Korea-based LifeSemantics has launched Redpill Breath, a digital therapeutics (DTx) for patients requiri...
EOFlow, a provider of wearable drug delivery systems (DDS), has announced that it has submitted a 510(k) application to ...
South Korea-based LegoChem Biosciences, Inc. (LCB) has entered into a research collaboration and license agree...
Amorepacific Corporation, a South Korean beauty and cosmetics conglomerate, has announced its successful execution of a ...
A study, co-led by Australia-based Griffith University’s Menzies Health Institute and South Korea’s Center f...
Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic ...
South Korean Ministry of Food and Drug Safety (MFDS) recently held a bilateral meeting with Health Sciences Authori...
South Korea-based SK Biopharmaceuticals has introduced its roadmap and vision for its digital healthcare business. ...
Over the past several months, the Korean Startup Center (KSC) Seattle and IntuitiveX (IX), in partnership with...
The Ministry of Health and Welfare and the Korea Health Promotion Institute held a ROK-ASEAN In...
South Korea-based Daewoong Pharmaceutical's "Envlo 0.3mg", a new sodium-glucose cotransporters 2 inhibitor (SGLT2) devel...
